Top Medical News

Expert Explains Significance of LAG-3 Inhibition in Novel Immunotherapies for Melanoma

January 28th 2022

LAG-3 represents a potentially relevant immune checkpoint pathway in melanoma treatment.

Geriatric Assessments Help Promote Comorbidity-Related Discussions in Patients With Advanced Cancer

January 28th 2022

A secondary analysis of the COACH study revealed that a geriatric assessment–guided intervention increased the number of comorbidity-related discussions between patients and providers.

Updated NCCN Guidelines Now Include Neratinib for HER2+ Breast Cancer

January 27th 2022

The update is in agreement with the FDA approval of a labeling supplement in June 2021 to the United States Prescribing Information for neratinib in HER2-positive breast cancer.

DNA Linked to Genitourinary Toxicity Risk With Radiation in Prostate Cancer

January 27th 2022

A newly designed model will outline what genetic patterns put men with prostate cancer at an increased risk of toxic side effects.

FDA Approves Tebentafusp to Treat HLA-A*02:01 Positive Uveal Melanoma

January 26th 2022

Tebentafusp is now the first FDA-approved therapy to treat unresectable or metastatic uveal melanoma.


Most Recent